Mardesic T, Müller P, Zetová L, Miková M, Stroufová A
Ustav pro péci o matku a dítĕ, Praha.
Ceska Gynekol. 1995 Apr;60(2):74-8.
Poor responders, whose cycles were cancelled after CC-hMG stimulation because of inadequate response, were stimulated with GnRH analogues (Suprefact nasal spray) and hMG in short protocol. In this highly negative selected group the cancellation rate was significantly lower (16.2%) than in the "normal" IVF population stimulated with clomiphene citrate and hMG (24.8%). All other parameters (number of oocytes and embryos, pregnancy rate) did not differ in the two groups. Embryos were frozen in 23.4% of cycles after GnRH-hMG stimulation and in 26.1% of cycles after CC-hMG stimulation. In GnRH-a cycles more ampoules (17.7) were injected per patient than after CC-hMG protocols (11.1 ampoules). Severe ovarian hyperstimulation syndrome developed in 4.0% CC-hMG cycles and in 2.8% cycles where GnRH analogues were used.
反应不良者,即因反应不足在克罗米芬-人绝经期促性腺激素(CC-hMG)刺激后周期被取消的患者,采用GnRH类似物(Suprefact鼻喷雾剂)和hMG进行短方案刺激。在这个经过高度阴性选择的组中,取消率显著低于用枸橼酸氯米芬和hMG刺激的“正常”体外受精人群(分别为16.2%和24.8%)。两组的所有其他参数(卵母细胞和胚胎数量、妊娠率)没有差异。GnRH-hMG刺激后23.4%的周期以及CC-hMG刺激后26.1%的周期中胚胎被冷冻。在GnRH-a周期中,每位患者注射的安瓿数(17.7)比CC-hMG方案后(11.1安瓿)更多。严重卵巢过度刺激综合征在4.0%的CC-hMG周期和2.8%使用GnRH类似物的周期中发生。